pharma · Bleeding Complication During Colon Polypectomy · Cancer of Colon
Yang Xiaotian
Yang Xiaotian is a pharma organization headquartered in CN. Primary therapeutic focus areas include Bleeding Complication During Colon Polypectomy, Cancer of Colon, Erosive Esophagitis, Gastric Cancer, Primary Aldosteron
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 5
- Drugs
- 2
- Patents
- 0
Blood test
Phase 2 · other · Cancer of Colon
Blood test for Cancer of Colon is a Phase 2 program (other) at Yang Xiaotian with 1 ClinicalTrials.gov record(s).
Internal code Soonchunhyang UH
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Yang Xiaotian
- Phase
- Phase 2
- Modality
- other
- Indication
- Cancer of Colon
- Status
- completed
- Trials
- 1